Whittier Trust CO Of Nevada Inc Apellis Pharmaceuticals, Inc. Transaction History

Whittier Trust CO Of Nevada Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$38.07 - $59.71 $1,180 - $1,851	31 Added 51.67%	91 $3,000
Q1 2024 May 02, 2024	SELL	$55.39 - $72.47 $110 - $144	-2 Reduced 3.23%	60 $3,000
Q3 2023 Oct 27, 2023	BUY	$23.65 - $89.22 $591 - $2,230	25 Added 67.57%	62 $2,000
Q2 2023 Jul 24, 2023	SELL	$76.68 - $93.31 $76 - $93	-1 Reduced 2.63%	37 $3,000
Q1 2023 Apr 21, 2023	BUY	$46.59 - $66.96 $1,770 - $2,544	38 New	38 $2,000

302

123M

2.63M

845K

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.68B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Whittier Trust CO Of Nevada Inc, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO Of Nevada Inc with notifications on news.